Company intelligence / Profile preview
Dorra Pharma
- Ownership
- Private
- Development stage
- Commercial
Overview
Dorra Pharma is a China-based pharmaceutical group specializing in R&D, manufacturing, and sales of small molecule APIs, intermediates, and finished formulations. The company has core technology strengths in bromination, enzyme/metal-catalyzed reactions, nitration, and hydrogenation. Its facilities are GMP-compliant with approvals from major regulatory agencies including the US FDA and Japan PMDA. It serves global markets with a focus on anti-infectives, cardiovascular drugs, digestive system agents, antithrombotics among others.
- Therapeutic areas
- GastroenterologyCardiovascularInfectious Diseases
- Modalities
- Small moleculeAPIs (Active Pharmaceutical Ingredients)IntermediatesFormulations
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Dorra Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dorra Pharma.